[Corticoid long-term therapy. Desired and undesired effects].
D000893:Anti-Inflammatory Agents; D003920:Diabetes Mellitus / Q000139:chemically induced; D004487:Edema / Q000139:chemically induced; D005128:Eye Diseases / Q000139:chemically induced; D005938:Glucocorticoids / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents; D010024:Osteoporosis / Q000139:chemically induced; D010248:Paramethasone / Q000009:adverse effects; D010437:Peptic Ulcer / Q000139:chemically induced; D011241:Prednisone / Q000009:adverse effects; D012871:Skin Diseases / Q000139:chemically induced; D013997:Time Factors; D014221:Triamcinolone / Q000009:adverse effects; D014882:Water-Electrolyte Balance
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D014221:Triamcinolone; D011241:Prednisone; D010248:Paramethasone
Kortikoid-Langzeitbehandlung. Erwünschte und unerwünschte Wirkungen.